“…[3][4][5][6][7] Synthetic biodegradable polymers based on poly(ε-caprolactone), poly(lactic acid), poly(glycolide), poly(p-dioxanone), poly(carbonates), and poly(α-amino acids) as well as copolymers made of these building blocks have been explored to create cell scaffolds for applications such as implants, stents, sutures, in drug delivery, wound dressings, as injectable ECMs, and in multiple other clinical applications. [8][9][10][11][12][13][14][15][16] Key advantages of these materials are the possibilities to easily tailor their chemical and mechanical properties as well as biodegradation simply by introducing small changes in their chemical compositions. [4,6,17] However, the structural space for these materials is massive and further modifications, for example by introducing entirely new physical properties, could result in tunable and new, unexpected cell-scaffold interactions.…”